Al-Andalus Innovation Venture – Scaleup Pitch Competition Finalist

Recognized as a finalist in the Scaleup Pitch Competition at Al-Andalus Innovation Venture 2024. The company was selected for its high growth potential and disruptive liquid biopsy technology, ClonSite, which enables the detection of one tumor cell among a million healthy cells to prevent cancer relapses.